By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Innocoll, Inc. 

42662 Kitchen Prim Court

Ashburn  Virginia  20148  U.S.A.
Phone: 610-459-4278 Fax: 610-459-2893


SEARCH JOBS


Industry
Pharmaceutical






Company News
Innocoll, Inc. (INNL) Announces First Patient Dosed In The Xaracoll MATRIX-1 Phase III Study For The Treatment Of Postoperative Pain 9/2/2015 6:54:16 AM
Innocoll, Inc. (INNL) Announces Second Quarter 2015 Financial And Operating Results And Updates Late-Stage Product Portfolio Progress 8/14/2015 10:17:39 AM
Innocoll, Inc. (INNL) Appoints Rich Fante As Chief Commercial Officer And Head Of Business Development 8/13/2015 7:47:20 AM
Innocoll, Inc. (INNL) To Report Second Quarter 2015 Financial Results And Host Webcast And Conference Call On August 14, 2015 8/7/2015 10:47:56 AM
Innocoll AG Appoints Jose Carmona As Chief Financial Officer 7/1/2015 7:05:54 AM
Innocoll, Inc. (INNL) Announces Qualified Infectious Disease Product (QIDP) Designation For Cogenzia For The Adjunctive Treatment Of Moderate And Severe Diabetic Foot Infection 6/30/2015 7:19:10 AM
Innocoll, Inc. (INNL) To Present At JMP Securities Healthcare Conference 6/18/2015 7:57:07 AM
Innocoll, Inc. (INNL) Announces First Patient Dosed In The Cogenzia COACT-2 Phase III Study For The Treatment Of Diabetic Foot Infection 6/15/2015 8:53:11 AM
Innocoll, Inc. (INNL) Announces First Patient Dosed In The Cogenzia COACT-1 Phase III Study For The Treatment Of Diabetic Foot Infection 5/15/2015 7:08:55 AM
Innocoll, Inc. (INNL) Announces First Quarter Financial And Operating Results 5/14/2015 1:26:49 PM
123456789
//-->